 INmune Bio, Inc. NASDAQ:INMB Q1 2022 Earnings Conference Call May 5, 2022 4:30 PM ET Company Participants David Moss Co-Founder and Chief Financial Officer RJ Tesi Chairman and Chief Executive Officer CJ Barnum Head of Neuroscience Conference Call Participants William Wood B. Riley Securities Matthew Cross Alliance Global Partners Sung Hong BTIG Daniel Carlson TW Research Group Operator Greetings, and welcome to the INmune Bio First Quarter 2022 Earnings Call. 